FDA NDC Directory · JSON-LD · Markdown

Proglycem

NDC 0575-6200 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namediazoxide
Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA017453
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDIAZOXIDE (50 mg/mL)
Marketing started19900930
Package count1

External sources

Source: openFDA. Public-domain (CC0).